HEATHER COOPER: Open Payments
NPI 1851054142 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 15 payments from 9 companies in 2025. Trend: 2023 $431 · 2024 $1,175 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 4 | $103 |
| ABBVIE INC. | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Janssen Biotech, Inc. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| PFIZER INC. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Averitas Pharma Inc. | 1 | $15 |
Products named: BRIUMVI, SKYRIZI, NUCALA, COSENTYX, OCTAGAM IMMUNE GLOBULIN (HUMAN), GLASSIA, SPEVIGO, QUTENZA.
Industry payments across TN — which companies pay providers there.
